In prostate carcinoma cells, SeNP did not significantly affect the expression of the seven studied selenoproteins; a twofold increase in the expression of SELENOT, SELENOK, SELENON, and DIO2 can be noted (Figure 8c). The gene discussed is SELENOK; the disease is prostate carcinoma.